Localization of TEIF in the centrosome and its functional association with centrosome amplification in DNA damage, telomere dysfunction and human cancers

Oncogene

Volumn 28, Issue 12, 2009, Pages 1549-1560

  Gong, Y ^a   Sun, Y ^a   McNutt, M A ^a   Sun, Q ^a   Hou, L ^a   Liu, H ^a   Shen, Q ^a   Ling, Y ^a   Chi, Y ^a   Zhang, B ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Cancer; Centrosome; DNA damage; Telomere dysfunction

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE TRANSCRIPTIONAL ELEMENT INTERACTING FACTOR; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL CYCLE; CELL TRANSPORT; CENTROSOME; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA DAMAGE; DNA REPAIR; DNA STRUCTURE; GENE AMPLIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOSIS; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SOFT TISSUE SARCOMA;

CELL LINE, TUMOR; CENTROSOME; DNA DAMAGE; HUMANS; NEOPLASMS; PROTEIN TRANSPORT; SARCOMA; TELOMERE; TELOMERE-BINDING PROTEINS; TRANSCRIPTION FACTORS;

EID: 63449104484     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.503     Document Type: Article

References (48)

1. Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. (2003). Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426: 570-574.
2. Bellon M, Nicot C. (2008). Regulation of telomerase and telomeres: human tumor viruses take control. J Natl Cancer Inst 100: 98-108.
3. Brinkley BR. (2001). Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol 11: 18-21.
4. Brown LA, Irving J, Parker R, Kim H, Press JZ, Longacre TA et al. (2006). Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas. Gynecol Oncol 100: 264-270.
5. Chikashige Y, Tsutsumi C, Yamane M, Okamasa K, Haraguchi T, Hiraoka Y. (2006). Meiotic proteins bqt1 and bqt2 tether telomeres to form the bouquet arrangement of chromosomes. Cell 125: 59-69.
6. Churikov D, Wei C, Price CM. (2006). Vertebrate POT1 restricts Goverhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection. Mol Cell Biol 26: 6971-6982.
7. Dou Z, Ding X, Zereshki A, Zhang Y, Zhang J, Wang F et al. (2004). TTK kinase is essential for the centrosomal localization of TACC2. FEBS Lett 572: 51-56.
8. Doxsey S. (2001a). Centrosomes as command centres for cellular control. Nat Cell Biol 3: E105-E108.
9. Doxsey S. (2001b). Re-evaluating centrosome function. Nat Rev Mol.Cell Biol 2: 688-698.
10. Doxsey S, McCollum D, Theurkauf W. (2005a). Centrosomes in cellular regulation. Annu Rev Cell Dev Biol 21: 411-434.
11. Doxsey S, Zimmerman W, Mikule K. (2005b). Centrosome control of the cell cycle. Trends Cell Biol 15: 303-311.
12. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F et al. (2003). Identification of Stk6/STK15 as a candidate low penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34: 403-412.
13. Fletcher L, Muschel RJ. (2006). The centrosome and the DNA damage induced checkpoint. Cancer Lett 243: 1-8.
14. Fukasawa K. (2005). Centrosome amplification, chromosome instability and cancer development. Cancer Lett 230: 6-19.
15. Gillingham AK, Munro S. (2000). The PACT domain, a conserved centrosomal targeting motif in the coiled-coil proteins AKAP450 and pericentrin. EMBO Rep 1: 524-529.
16. Gisselsson D. (2001). Ring chromosomes: vicious circles at the end and beginning of life. Atlas of Genetics and Cytogenetics in Oncology and Haematology. URL:http://AtlasGeneticsOncology.org/Deep/ChromosomInstabilID20023. html.
17. Gisselsson D. (2003). Chromosome instability in cancer: how, when, and why? Adv Cancer Res 87: 1-29.
18. Gisselsson D. (2005). Mitotic instability in cancer: is there method in the madness? Cell Cycle 4: 1007-1010.
19. Gisselsson D, Gorunova L, Höglund M, Mandahl N, Elfving P. (2004). Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer 91: 327-332.
20. Gisselsson D, Jonson T, Yu C, Martins C, Mandahl N, Wiegant J et al. (2002). Centrosomal abnormalities, multipolar mitoses, and chromosomal instability in head and neck tumors with dysfunctional telomeres. Br J Cancer 87: 202-207.
21. Gisselsson D, Lv M, Tsao SW,Man C, Jin C, Höglund M et al. (2005). Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma. Genes Chromosomes Cancer 42: 22-33.
22. Hackett JA, Greider CW. (2002). Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 21: 619-626.
23. Hara T, Matsumura-Arioka Y, Ohtani K, Nakamura M. (2008). Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells. Cancer Sci 99: 1155-1163.
24. Lavia P, Mileo AM, Giordano A, Paggi MG. (2003). Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability. Oncogene 22: 6508-6516.
25. Lingle WL, Salisbury JL. (2000). The role of the centrosome in the development of malignant tumors. Curr Top Dev Biol 49: 313-329.
26. Loffler H, Lukas J, Bartek J, Kramer A. (2006). Structure meets functioncentrosomes, genome maintenance and the DNA damage response. Exp Cell Res 312: 2633-2640.
27. Lou Y, Xie W, Zhang DF, Yao JH, Luo ZF, Wang YZ et al. (2004). Nek2A specifies the centrosomal localization of Erk2. Biochem Biophys Res Commun 321: 495-501.
28. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB et al. (2003). Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253.
29. Matsumoto Y, Maller JL. (2004). A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry. Science 306: 885-888.
30. McPherson JP, Hande MP, Poonepalli A, Lemmers B, Zablocki E, Migon E. (2006). A role for Brca1 in chromosome end maintenance. Hum Mol Genet 156: 831-838.
31. Momotani K, Khromov AS, Miyake T, Stukenberg PT, Somlyo AV. (2008). Cep57, a multidomain protein with unique microtubule and centrosomal localization domains. Biochem J 412: 265-273.
32. Morris VB, Brammall J, Noble J, Reddel R. (2000). p53 localizes to the centrosomes and spindles of mitotic cells in the embryonic chick epiblast, human cell lines, and a human primary culture: an immunofluorescence study. Exp Cell Res 256: 122-130.
33. Ohta T, Essner R, Ryu JH, Palazzo RE, Uetake Y, Kuriyama R. (2002). Characterization of Cep135, a novel coiled-coil centrosomal protein involved in microtubule organization in mammalian cells. J Cell Biol 1561: 87-99.
34. Peset I, Vernos I. (2008). The TACC proteins: TACC-ling microtubule dynamics and centrosome function. Trends Cell Biol 18: 379-388.
35. Pihan GA, Doxsey SJ. (1999). The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol 9: 289-302.
36. Plug-DeMaggio AW, Sundsvold T, Wurscher MA, Koop JI, Klingelhutz AJ, McDougall JK. (2004). Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene 23: 3561-3571.
37. Pumfery A, de la Fuente C, Kashanchi F. (2006). HTLV-1 Tax: centrosome amplification and cancer. Retrovirology 3: 50.
38. Saunders W. (2005). Centrosomal amplification and spindle multipolarity in cancer cells. Semin Cancer Biol 15: 25-32.
39. Slijepcevic P. (2006). The role of DNA damage response proteins at telomeresan 'integrative' model. DNA Repair (Amst) 5: 1299-1306.
40. Smith S, de Lange T. (1999). Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci 112: 3649-3656.
41. Stenoien DL, Sen S, Mancini MA, Brinkley BR. (2003). Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle. Cell Motil Cytoskeleton 55: 134-146.
42. Tang Z, Zhang B, Xu W, Zhao Y, Hou L. (2003). Characterization of telomerase regulation-associated gene TRAP on tumor biology. J Peking Univ Health Sci 35: 402-407.
43. Tang Z, Zhao Y, Mei F, Yang S, Li X, Lv J et al. (2004). Molecular cloning and characterization of a human gene involved in transcriptional regulation of hTERT. Biochem Biophys Res Commun 324: 1324-1333.
44. van Asseldonk M, Schepens M, de Bruijn D, Janssen B, Merkx G, Geurts van Kessel A. (2000). Construction of a 350-kb sequenceready 11q13 cosmid contig encompassing the markers D11S4933 and D11S546: mapping of 11 genes and 3 tumor-associated translocation breakpoints. Genomics 66: 35-42.
45. Wang X, Liu L, Montagna C, Ried T, Deng CX. (2007). Haploinsufficiency of Parp1 accelerates Brca1-associated centrosome amplification, telomere shortening, genetic instability, apoptosis, and embryonic lethality. Cell Death Differ 14: 924-931.
46. Wong KF. (1999). 11q13 is a cytogenetically promiscuous site in hematologic malignancies. Cancer Genet Cytogenet 113: 93-95.
47. Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G et al. (2003). High-throughput tissue microarray analysis of 11q13 gene amplification CCND1, FGF3, FGF4, EMS1 in urinary bladder cancer. J Pathol 201: 603-608.
48. Zhao Y, Zheng J, Ling Y, Hou L, Zhang B. (2005). Transcriptional upregulation of DNA polymerase b by telomerase transcriptional elements-interacting factor. Biochem Biophys Res Commun 333: 908-916.